Topical Drug Delivery Market

Topical Drug Delivery Market Size by Type (Semi Solid Formulation, Solid Formulation, Liquid Formulation, Transdermal Products), Route of Administration (Skin, Ophthalmic, Rectal, Vaginal, Nasal), End User, Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2021 to 2028

Base Year: 2020 Historical Data: 2018-19
  • Report ID: TBI-12563
  • Published Date: Oct, 2021
  • Pages: 222
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global topical drug delivery market is expected to reach USD 158.76 billion by 2028, at a CAGR of 5.83% during the forecast period 2021-2028.Increasing demand for semi-solid formulation such as gel and ointments driving the growth of tropical drug delivery market.

Market Overview:

The topical drug delivery refers to the introduction of the drug in the body via the surface of the body in the formulation which can be absorbed. It is one of the easiest and accessible routes of administration of drug delivery. Topical drug delivery includes a large number of pharmaceutical dosage, including semi-solid formulation, solid powder, liquid formulations, and sprays. Most commonly used semi-solid formulation for the topical drug delivery is a gel, cream, and ointments. In the topical drug delivery, the skin is the most accessible and main organ of the body. Some of the benefits of topical drug delivery are easy and convenient to apply, easy to terminate the medication, better patient compliance, and self-medications.

Topical drug delivery system offers a suitable drug delivery system because they are less greasy and can be easily removed from the skin. Among all the gel application provides stability and better application stability as compared to cream and ointments. For the treatment and prevention of ocular disease, most of the patients treated with the topical drug delivery such as eye drop or ointments. The topical drug delivery system is generally used for the localized effects at the site of application to penetrate the drug into the underline layers of skin or mucous membrane. The topical drug delivery system is mainly used where the other drug delivery system does not work. These are commonly used for pain management, contraception, and urinary incontinence.

Get an overview of this study by requesting a free sample

Market Dynamics:

Drivers:

  • Increasing prevalence of skin disorders across world wide

Skin diseases are ranked as the fourth common cause of human illness and affect millions of people worldwide. Skin disorders are the most common and increase the overall burden on the healthcare system. Genetic factors, ageing, and environmental factor are some of the leading causes for the development of skin disorders. Topical drug delivery system is one of the most common methods used for drug delivery for skin disorders. The human skin is one of the most preferred routes for topical drug delivery. The topical drug exerts their action at the surface of the skin, or underline tissues. Thus, increasing prevalence of skin disorders driving the growth of the market. 

  • Rising incidences of eye and ear disorders

With the increasing incidences of eye and ear disorders, the demand is rising for the eye and ear drops. There is an increasing eye disorder due to changing lifestyle, chronic diseases, and ageing factor across the globe. Currently, there are more than 200 eye conditions ranging from common problems to rear disorders. Some of these have no symptoms and can cause loss of sight. In addition to this, there is an increasing prevalence of ear disorders across the globe. Thus, rising incidences of eye and ear disorders, driving the growth of the market.

Restraints:

  • Increasing preference for the alternative mode of drug delivery

Increasing preference for the alternative mode of drug delivery is one of the main factors which may hamper the growth of the market. Some of the alternative modes of drug delivery include enteral (gastrointestinal tract), parenteral (via injections), inhalation, and oral route. Currently, oral and parenteral are some of the leading modes for drug delivery. Thus, increasing preference for the alternative mode of drug delivery hampering the growth of the market.

Opportunities:

  • Increasing spending on the dermatology

Skin disease is one of the most common disorder across the globe. Approximately one-third of the population is affected by pathological skin disorder in their lifetime. Currently, there is around 25% of total healthcare spending on dermatology. Thus, increasing spending on dermatology is likely to provide new growth opportunities in the market.

Challenges:

  • Stringent government regulation on topical drug delivery

Like all other pharmaceuticals, there are also stringent government regulations for the topical drug delivery system to ensure the safety and efficacy of the drug during shelf life and during release. In addition to this, there is also regulation for drug quality and product performance. Thus, the rise in stringent government regulation may hamper the growth of the market over the forecast period.

Segmentation Analysis:

The global topical drug delivery market has been segmented based on type, route of administration, end user, and regions.

  • The type segment is divided into the semi-solid formulation, solid formulation, liquid formulation, and transdermal products. The semi-solid formulation accounted for the largest market share of 55.65% in the year 2020. The semi-solid formation includes cream, ointment, lotion, and pastes. The growth is mainly due to faster drug release and increased patient acceptability. 
  • The route of administration segment includes skin, ophthalmic, rectal, vaginal, and nasal. The skin segment dominated the global topical drug delivery market and held a market share of 70.25% in the year 2020. This is mainly attributed to increasing skin-related disorders across the globe. In addition to this, the skin is the most commonly used, easy, and accessible surface for topical drug delivery.   
  • The end-user segment includes hospitals & private clinics, home care settings, and others. Home care setting is projected to grow at the highest CAGR of 6.5% over the forecast period. Increasing number of patients who are opting for the home care service driving the growth of the market.

Regional Segmentation Analysis:

The regions analyzed for the global topical drug delivery market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. The North America region accounted for the major market share of 42.45% in the year 2020.

  • The growth is mainly due to the high prevalence of skin disorders and high awareness about skin-related diseases across the region. The skin problem is a common disorder in the U.S., especially in the elderly, and it rises with age. According to the Journal of the American Academy of Dermatology, approximately 85.25 million–one in four is impacted by skin disease. Thus, rising skin problems among the population are one of the key factor driving the growth of the market in North America.
  • The Asia Pacific region projected to grow at the highest CAGR of 6.9% over the forecast period. The growth is mainly due to increasing healthcare spending in countries such as India and China. In addition to this, increasing geriatric population in countries such as Japan and South Korea, further driving the growth of the market in the Asia Pacific region.  

North America Topical Drug Delivery Market Share in 2020- 42.45%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Competitive Analysis:

The key players of global topical drug delivery market are majorly focusing on adoption of various strategies such as new product development, joint venture, collaboration, technological integration, product innovations, mergers & acquisitions, and partnerships to gain the significant market share in the industry.

In August 2019, Bausch Health Companies Inc. announced that the company has received the Food and Drug Administration (FDA) approval for DUOBRII (halobetasol propionate and tazarotene) Lotion, 0.01%/0.045%, for the topical treatment of plaque psoriasis in adults.

In February 2020, GlaxoSmithKline announced that the company has received the Food and Drug Administration (FDA) approval forVoltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID), an over-the-counter (OTC) product for the temporary relief of arthritis pain.

List of Key Market Players:

  • Bausch Health Companies
  • Johnson & Johnson
  • GlaxoSmithKline
  • Bayer AG
  • CrescitaTherapeutics Inc.
  • Novartis AG
  • Glenmark Pharmaceuticals
  • Merck & Co
  • Hisamitsu Pharmaceutical
  • Cipla Ltd
  • Mylan

Key Target Audience

  • Government Bodies
  • Investors/Shareholders
  • Regulatory bodies
  • Environmental Agencies
  • Pharmaceutical Companies
  • API Manufacturers

Report Description:

  • Global Topical Drug Delivery Market, Industry Analysis, Trends, Analysis and Forecast, 2021 to 2028 is a forthcoming/imminent research report which is to be published by The Brainy Insights.
  • 2020 is considered as the base year of the report. 2018 and 2019 are considered as the historic years and 2021 to 2028 are the forecast years. The global topical drug delivery market is based on revenue (USD Million/Billion). The report incorporates the market study on the basis of revenue. The study covers the market share revenue/market share for each of the segments, regions and countries catering to global topical drug delivery market. The regions analyzed for the market are Europe, Asia Pacific, North America, South America and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
  • The report encompasses with the relative data & information, which have been validated by the leading industry professionals and experts all across the globe. The research report also delivers an outline of the attractiveness of topical drug delivery and regions which are deduced and formulated on the basis of their growth rate (CAGR), market size, and attractiveness by analyzing the present and future prospects to market growth and development in future.
  • The report illustrates the detailed (both quantitative and qualitative) analysis of historical data, revenues, key developments, along with the crucial strategies adopted by key organizations catering to global topical drug delivery market. This offers vital and in depth insights in order to depict the overall market scenario.
  • The report offers the detailed study for the company profiles of key organizations operating in the global topical drug delivery market and a comparative assessment based on their product offering, business overviews, geographic presence, business strategies, segment market share, product development &innovations, recent developments, joint venture, partnerships, mergers & acquisitions, strategic alliances, SWOT analysis, and key financial information. This helps in evaluating the overall competition present in the market scenario. 
  • The report provides an elaborative assessment of the porter’s five forces analysis coupled with SWOT analysis so as to provide business related data and information’s. Porter’s five forces model is analyzed to understand the overall competitive scenario that is prevailing in the market. Additionally, the SWOT analysis identifies both the positive and negative attributes of the market development which influences the company growth and development in order to sustain and survive in the long run.
  • Along with that, the report also focuses on the market related driving factors, growth limitations (restraints), potential industry opportunities, significant trends and development which act as a key potential for the investors. 
  • Potential growth prospects along with the penetration rate analysis of the products (market related i.e., global topical drug delivery market is covered in order to comprehend the adoption rate and evaluate the market size.

Frequesntly Asked Questions

As per The Brainy Insights, the size of the topical drug delivery market was valued at USD 100.64 billion in 2020 and is anticipated to reach USD 158.76 billion by 2028.

Global topical drug delivery market is growing at a CAGR of 5.83% during the forecast period 2021-2028.

The global topical drug delivery market has been segmented based on type, route of administration end-user, and regions. Thesemi solid segment dominated the global market and held the largest market share in the year 2020.

The North America region emerged as the largest market for the topical drug delivery.

Increasing prevalence of skin disorders is one of the key significant factor driving the growth of market

Rising preference for the alternative drug delivery may limit the growth of the market over the forecast period.

Increasing spending on dermatology is expected to offer the future growth opportunity in the market.

Key players are Bausch Health Companies, Johnson & Johnson, GlaxoSmithKline, Bayer AG, Crescita Therapeutics Inc., Novartis AG, and Glenmark Pharmaceuticals, among others.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Type
          4.3.2. Market Attractiveness Analysis By Route of Administration
          4.3.3. Market Attractiveness Analysis By End User
          4.3.4. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Increasing prevalence of skin disorders across worldwide
          5.2.2. Rising incidences of eye and ear disorders
    5.3. Restrains
          5.3.1. Increasing preference for the alternative mode of drug delivery
    5.4. Opportunities
          5.4.1. Increasing spending on the dermatology
    5.5. Challenges
          5.5.1. Stringent government regulation on topical drug delivery

6. Global Topical Drug Delivery Market Analysis and Forecast, By Type
    6.1. Segment Overview
    6.2. Semi-Solid Formulation
    6.3. Solid Formulation
    6.4. Liquid Formulation
    6.5. Transdermal Products

7. Global Topical Drug Delivery Market Analysis and Forecast, By Route of Administration
    7.1. Segment Overview
    7.2. Skin
    7.3. Ophthalmic
    7.4. Rectal
    7.5. Vaginal
    7.6. Nasal

8. Global Topical Drug Delivery Market Analysis and Forecast, By End User
    8.1. Segment Overview
    8.2. Hospitals & Private Clinics
    8.3. Home Care Settings
    8.4. Others

9. Global Topical Drug Delivery Market Analysis and Forecast, By Regional Analysis
    9.1. Segment Overview
    9.2. North America
          9.2.1. U.S.
          9.2.2. Canada
          9.2.3. Mexico
    9.3. Europe
          9.3.1. Germany
          9.3.2. France
          9.3.3. U.K.
          9.3.4. Italy
          9.3.5. Spain
    9.4. Asia-Pacific
          9.4.1. Japan
          9.4.2. China
          9.4.3. India
    9.5. South America
          9.5.1. Brazil
    9.6. Middle East and Africa
          9.6.1. UAE
          9.6.2. South Africa

10. Global Topical Drug Delivery Market-Competitive Landscape
    10.1. Overview
    10.2. Market Share of Key Players in the Topical Drug Delivery Market
          10.2.1. Global Company Market Share
          10.2.2. North America Company Market Share
          10.2.3. Europe Company Market Share
          10.2.4. APAC Company Market Share
    10.3. Competitive Situations and Trends
          10.3.1. Product Launches and Developments
          10.3.2. Partnerships, Collaborations, and Agreements
          10.3.3. Mergers & Acquisitions
          10.3.4. Expansions

11. Company Profiles
    11.1. Bausch Health Companies
          11.1.1. Business Overview
          11.1.2. Company Snapshot
          11.1.3. Company Market Share Analysis
          11.1.4. Company Product Portfolio
          11.1.5. Recent Developments
          11.1.6. SWOT Analysis
    11.2. Johnson & Johnson
          11.2.1. Business Overview
          11.2.2. Company Snapshot
          11.2.3. Company Market Share Analysis
          11.2.4. Company Product Portfolio
          11.2.5. Recent Developments
          11.2.6. SWOT Analysis
    11.3. GlaxoSmithKline
          11.3.1. Business Overview
          11.3.2. Company Snapshot
          11.3.3. Company Market Share Analysis
          11.3.4. Company Product Portfolio
          11.3.5. Recent Developments
          11.3.6. SWOT Analysis
    11.4. Bayer AG
          11.4.1. Business Overview
          11.4.2. Company Snapshot
          11.4.3. Company Market Share Analysis
          11.4.4. Company Product Portfolio
          11.4.5. Recent Developments
          11.4.6. SWOT Analysis
    11.5. Crescita Therapeutics Inc.
          11.5.1. Business Overview
          11.5.2. Company Snapshot
          11.5.3. Company Market Share Analysis
          11.5.4. Company Product Portfolio
          11.5.5. Recent Developments
          11.5.6. SWOT Analysis
    11.6. Novartis AG
          11.6.1. Business Overview
          11.6.2. Company Snapshot
          11.6.3. Company Market Share Analysis
          11.6.4. Company Product Portfolio
          11.6.5. Recent Developments
          11.6.6. SWOT Analysis
    11.7. Glenmark Pharmaceuticals
          11.7.1. Business Overview
          11.7.2. Company Snapshot
          11.7.3. Company Market Share Analysis
          11.7.4. Company Product Portfolio
          11.7.5. Recent Developments
          11.7.6. SWOT Analysis
    11.8. Merck & Co
          11.8.1. Business Overview
          11.8.2. Company Snapshot
          11.8.3. Company Market Share Analysis
          11.8.4. Company Product Portfolio
          11.8.5. Recent Developments
          11.8.6. SWOT Analysis
    11.9. Hisamitsu Pharmaceutical
          11.9.1. Business Overview
          11.9.2. Company Snapshot
          11.9.3. Company Market Share Analysis
          11.9.4. Company Product Portfolio
          11.9.5. Recent Developments
          11.9.6. SWOT Analysis
    11.10. Cipla Ltd
          11.10.1. Business Overview
          11.10.2. Company Snapshot
          11.10.3. Company Market Share Analysis
          11.10.4. Company Product Portfolio
          11.10.5. Recent Developments
          11.10.6. SWOT Analysis
 

List of Table

1. Global Topical Drug Delivery Market, By Type , 2018–2028 (USD Billion)

2. Global Semi Solid Formulation, Topical Drug Delivery Market, By Region, 2018–2028 (USD Billion)

3. Global Solid Formulation, Topical Drug Delivery Market, By Region, 2018–2028 (USD Billion)

4. Global Liquid Formulation, Topical Drug Delivery Market, By Region, 2018–2028 (USD Billion)

5. Global Transdermal Products,  Topical Drug Delivery Market, By Region, 2018–2028 (USD Billion)

6. Global Topical Drug Delivery Market, By Route of Administration, 2018–2028 (USD Billion)

7. Global Skin, Topical Drug Delivery Market, By Region, 2018–2028 (USD Billion)

8. Global Ophthalmic Topical Drug Delivery Market, By Region, 2018–2028 (USD Billion)

9. Global Rectal, Topical Drug Delivery Market, By Region, 2018–2028 (USD Billion)

10. Global Virginal, Topical Drug Delivery Market, By Region, 2018–2028 (USD Billion)

11. Global Nasal, Topical Drug Delivery Market, By Region, 2018–2028 (USD Billion)

12. Global Topical Drug Delivery Market, By End User, 2018–2028 (USD Billion)

13. Global Hospital, Topical Drug Delivery Market, By Region, 2018–2028 (USD Billion)

14. Global Home Care, Topical Drug Delivery Market, By Region, 2018–2028 (USD Billion)

15. Global Others Topical Drug Delivery Market, By Region, 2018–2028 (USD Billion)

16. Global Topical Drug Delivery Market, By Region, 2018–2028 (USD Billion)

17. North America Topical Drug Delivery Market, By Type , 2018–2028 (USD Billion)

18. North America Topical Drug Delivery Market, By Route of Administration, 2018–2028 (USD Billion)

19. North America Topical Drug Delivery Market, By End User, 2018–2028 (USD Billion)

20. U.S. Topical Drug Delivery Market, By Type , 2018–2028 (USD Billion)

21. U.S. Topical Drug Delivery Market, By Route of Administration, 2018–2028 (USD Billion)

22. U.S. Topical Drug Delivery Market, By End User, 2018–2028 (USD Billion)

23. Canada Topical Drug Delivery Market, By Type , 2018–2028 (USD Billion)

24. Canada Topical Drug Delivery Market, By Route of Administration, 2018–2028 (USD Billion)

25. Canada Topical Drug Delivery Market, By End User, 2018–2028 (USD Billion)

26. Mexico Topical Drug Delivery Market, By Type , 2018–2028 (USD Billion)

27. Mexico Topical Drug Delivery Market, By Route of Administration, 2018–2028 (USD Billion)

28. Mexico Topical Drug Delivery Market, By End User, 2018–2028 (USD Billion)

29. Europe Topical Drug Delivery Market, By Type , 2018–2028 (USD Billion)

30. Europe Topical Drug Delivery Market, By Route of Administration, 2018–2028 (USD Billion)

31. Europe Topical Drug Delivery Market, By End User, 2018–2028 (USD Billion)

32. Germany Topical Drug Delivery Market, By Type , 2018–2028 (USD Billion)

33. Germany Topical Drug Delivery Market, By Route of Administration, 2018–2028 (USD Billion)

34. Germany Topical Drug Delivery Market, By End User, 2018–2028 (USD Billion)

35. France Topical Drug Delivery Market, By Type , 2018–2028 (USD Billion)

36. France Topical Drug Delivery Market, By Route of Administration, 2018–2028 (USD Billion)

37. France Topical Drug Delivery Market, By End User, 2018–2028 (USD Billion)

38. U.K. Topical Drug Delivery Market, By Type , 2018–2028 (USD Billion)

39. U.K. Topical Drug Delivery Market, By Route of Administration, 2018–2028 (USD Billion)

40. U.K. Topical Drug Delivery Market, By End User, 2018–2028 (USD Billion)

41. Italy Topical Drug Delivery Market, By Type , 2018–2028 (USD Billion)

42. Italy Topical Drug Delivery Market, By Route of Administration, 2018–2028 (USD Billion)

43. Italy Topical Drug Delivery Market, By End User, 2018–2028 (USD Billion)

44. Spain Topical Drug Delivery Market, By Type , 2018–2028 (USD Billion)

45. Spain Topical Drug Delivery Market, By Route of Administration, 2018–2028 (USD Billion)

46. Spain Topical Drug Delivery Market, By End User, 2018–2028 (USD Billion)

47. Asia Pacific Topical Drug Delivery Market, By Type , 2018–2028 (USD Billion)

48. Asia Pacific Topical Drug Delivery Market, By Route of Administration, 2018–2028 (USD Billion)

49. Asia Pacific Topical Drug Delivery Market, By End User, 2018–2028 (USD Billion)

50. Japan Topical Drug Delivery Market, By Type , 2018–2028 (USD Billion)

51. Japan Topical Drug Delivery Market, By Route of Administration, 2018–2028 (USD Billion)

52. Japan Topical Drug Delivery Market, By End User, 2018–2028 (USD Billion)

53. China Topical Drug Delivery Market, By Type , 2018–2028 (USD Billion)

54. China Topical Drug Delivery Market, By Route of Administration, 2018–2028 (USD Billion)

55. China Topical Drug Delivery Market, By End User, 2018–2028 (USD Billion)

56. India Topical Drug Delivery Market, By Type , 2018–2028 (USD Billion)

57. India Topical Drug Delivery Market, By Route of Administration, 2018–2028 (USD Billion)

58. India Topical Drug Delivery Market, By End User, 2018–2028 (USD Billion)

59. South America Topical Drug Delivery Market, By Type , 2018–2028 (USD Billion)

60. South America Topical Drug Delivery Market, By Route of Administration, 2018–2028 (USD Billion)

61. South America Topical Drug Delivery Market, By End User, 2018–2028 (USD Billion)

62. Brazil Topical Drug Delivery Market, By Type , 2018–2028 (USD Billion)

63. Brazil Topical Drug Delivery Market, By Route of Administration, 2018–2028 (USD Billion)

64. Brazil Topical Drug Delivery Market, By End User, 2018–2028 (USD Billion)

65. Middle East and Africa Topical Drug Delivery Market, By Type , 2018–2028 (USD Billion)

66. Middle East and Africa Topical Drug Delivery Market, By Route of Administration, 2018–2028 (USD Billion)

67. Middle East and Africa Topical Drug Delivery Market, By End User, 2018–2028 (USD Billion)

68. UAE Topical Drug Delivery Market, By Type , 2018–2028 (USD Billion)

69. UAE Topical Drug Delivery Market, By Route of Administration, 2018–2028 (USD Billion)

70. UAE Topical Drug Delivery Market, By End User, 2018–2028 (USD Billion)

71. South Africa Topical Drug Delivery Market, By Type , 2018–2028 (USD Billion)

72. South Africa Topical Drug Delivery Market, By Route of Administration, 2018–2028 (USD Billion)

73. South Africa Topical Drug Delivery Market, By End User, 2018–2028 (USD Billion)

List of Figures 

1. Global Topical Drug Delivery Market Segmentation

2. Topical Drug Delivery Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Topical Drug Delivery Market Attractiveness Analysis By Type 

9. Global Topical Drug Delivery Market Attractiveness Analysis By Route of Administration

10. Global Topical Drug Delivery Market Attractiveness Analysis By End User

11. Global Topical Drug Delivery Market Attractiveness Analysis By Region

12. Global Topical Drug Delivery Market: Dynamics

13. Global Topical Drug Delivery Market Share By Type (2021 & 2028)

14. Global Topical Drug Delivery Market Share By Route of Administration(2021 & 2028)

15. Global Topical Drug Delivery Market Share By End User(2021 & 2028)

16. Global Topical Drug Delivery Market Share by Regions (2021 & 2028)

17. Global Topical Drug Delivery Market Share by Company (2020)

This study forecasts revenue and volume growth at global, regional, and country levels from 2018 to 2028. The Brainy Insights has segmented the global Topical Drug Delivery market on the basis of below mentioned segments:

Global Topical Drug Delivery Market by Type:

  • Semi Solid Formulation
  • Solid Formulation
  • Liquid Formulation
  • Transdermal Products

Global Topical Drug Delivery Market by Route of Administration:

  • Skin
  • Ophthalmic
  • Rectal
  • Vaginal
  • Nasal

Global Topical Drug Delivery Market by End User:

  • Hospital & Clinics
  • Home Care Settings
  • Others

Global Topical Drug Delivery Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date